Study Confirms APOE Role In Higher Specificity Alzheimer's Diagnosis
This article was originally published in The Gray Sheet
Executive Summary
Apolipoprotein E (APOE) genotyping raises the specificity of diagnosing Alzheimer's disease (AD) to 84% in patients with dementia when used in conjunction with clinical diagnosis, according to a study in the Feb. 19 New England Journal of Medicine.